Patents by Inventor Margaret T. Weis

Margaret T. Weis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9861647
    Abstract: Calcium glycerophosphate is found to be effective in treating and preventing a disease, disorder and/or condition of the respiratory system. The disease, disorder and/or condition is related to an obstructive or a restrictive condition of the respiratory airway.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: January 9, 2018
    Assignee: Prelief, Inc.
    Inventors: Alan E. Kligerman, Margaret T. Weis
  • Publication number: 20160250235
    Abstract: Calcium glycerophosphate is found to be effective in treating and preventing a disease, disorder and/or condition of the respiratory system. The disease, disorder and/or condition is related to an obstructive or a restrictive condition of the respiratory airway.
    Type: Application
    Filed: May 11, 2016
    Publication date: September 1, 2016
    Inventors: Alan E. KLIGERMAN, Margaret T. WEIS
  • Patent number: 9358242
    Abstract: Calcium glycerophosphate is found to be effective in treating and preventing a disease, disorder and/or condition of the respiratory system. The disease, disorder and/or condition is related to an obstructive or a restrictive condition of the respiratory airway.
    Type: Grant
    Filed: March 1, 2010
    Date of Patent: June 7, 2016
    Assignee: Prelief Inc.
    Inventors: Alan E. Kligerman, Margaret T. Weis
  • Publication number: 20150374725
    Abstract: Methods and compositions for treating and preventing intestinal injury are described. In particular, methods and delayed-release enteric coated compositions of glycerophosphate salts for treating and preventing an intestinal injury, such as exercise-induced intestinal injury, intestinal injury induced or aggravated by ingestion of a nonsteroidal anti-inflammatory drug (NSAID), or exercise-induced intestinal injury aggravated by an NSAID, are described. Orally or nasally administering a therapeutically effective amount of a glycerophosphate salt, particularly calcium glycerophosphate, to a subject engaging in exercise, particularly a subject engaging in exercise and ingesting a NSAID for the treatment or prevention of musculoskeletal pain resulting from exercise, reduces exercise-induced intestinal injury, particularly exercise-induced intestinal injury aggravated by the NSAID. A method of increasing tight junction integrity in a subject in need thereof is also described.
    Type: Application
    Filed: February 20, 2014
    Publication date: December 31, 2015
    Inventors: Alan E. KLIGERMAN, Margaret T. WEIS
  • Publication number: 20100158819
    Abstract: Calcium glycerophosphate is found to be effective in treating and preventing a disease, disorder and/or condition of the respiratory system. The disease, disorder and/or condition is related to an obstructive or a restrictive condition of the respiratory airway.
    Type: Application
    Filed: March 1, 2010
    Publication date: June 24, 2010
    Applicant: PRELIEF INC.
    Inventors: Alan E. Kligerman, Margaret T. Weis